PCI announces serialisation installation at Tredegar site

This latest installation increases the companies' serialisation capability to support clients in advance of implementation dates for the European Falsified Medicines Directive

PCI Pharma Services (PCI) has installed and validated its latest comprehensive serialisation system, located at its manufacturing Center of Excellence in Tredegar, UK.

The investment demonstrates PCI’s continued investment in and expansion of market-leading serialisation capabilities. This latest installation increases PCI’s serialisation capability to support clients in advance of implementation dates for the European Falsified Medicines Directive (EU FMD), as well as supply for the US and emerging markets, including countries such as China, Turkey, Brazil, Saudi Arabia and others.

PCI’s system is compliant to all EU member country requirements for serialisation and specialised labelling, including application and integration of advanced anticounterfeiting technologies.

The highly flexible technology delivers machine and human-readable coding, tamper evident solutions and Bollini labelling – which in turn is linked to a case loading and aggregation station, with a final aggregation station connecting cases to pallet. PCI is a strong supporter of the advanced use of aggregation to support product security, realising the significant benefits in packaging operations, as well as the broader pharmaceutical supply chain.

PCI’s site in Tredegar, South Wales, UK already offers excellence in potent manufacturing services for customers globally, and this new serialisation technology further strengthens its comprehensive offering. This investment in the Tredegar facility is part of a significant global initiative to develop the serialisation services across PCI’s global network, which will ultimately exceed more than 90 lines.

Commenting on this latest investment, Jim Neville, Director of Operations, Tredegar, said: “This is an important addition to the site’s capabilities. Being able to offer this fully flexible service and work in partnership with our customers to deliver a trusted, seamless service is critical, and being ahead of the timelines with this offering ensures compliance with the EU FMD.”

PCI has been actively serialising commercial products for the US, EU and international markets for the past 6 years.

The integrated technology strategy enables operators in all PCI’s global locations to operate the same graphical user interface, providing a seamless global service. PCI clients enjoy singular connectivity to all PCI sites.

Featured Companies

PCI Pharma Services (more information, website)